レバミゾールは,ハンセン病の治療にダプソン添加剤として使用されています.

Ultra-fast single-crystal CVD diamonds in the particle time-of-flight (PTOF) detector for low yield burn-history measurements on the NIF (invited).

The Review of scientific instruments·2025

Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations.

Gynecologic oncology·2025

Distribution and Characteristics of Congenital Cardiac Surgery Centers within Bangladesh.

Mymensingh medical journal : MMJ·2024

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022

The fasted and post-prandial physiological responses of the Patagonian blennie Eleginops maclovinus.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·2022

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Unveiling the sumatriptan dose-relief relationship.

European journal of clinical pharmacology·2026

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Biological & pharmaceutical bulletin·2026

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

International journal of pharmaceutics·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

関連する実験動画

レバミゾールは,ハンセン病の治療にダプソン添加剤として使用されています.

関連する概念動画

Ultra-fast single-crystal CVD diamonds in the particle time-of-flight (PTOF) detector for low yield burn-history measurements on the NIF (invited).

Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations.

Distribution and Characteristics of Congenital Cardiac Surgery Centers within Bangladesh.

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

The fasted and post-prandial physiological responses of the Patagonian blennie Eleginops maclovinus.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Unveiling the sumatriptan dose-relief relationship.

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

関連する実験動画

レバミゾールは,ハンセン病の治療にダプソン添加剤として使用されています.

関連する概念動画

関連記事